Skip to content

Short-term Caregiver Psychotherapy

Psychotherapeutical Short-term Intervention for Caregivers of Persons With Dementia

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02175953
Enrollment
13
Registered
2014-06-26
Start date
2014-06-30
Completion date
2016-05-31
Last updated
2016-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caregiver Burden of People With Dementia

Keywords

caregiver burden, stress, depression, dementia

Brief summary

This study is to test the feasibility (pilot part) and efficacy (phase IIa part) of a specifically on the needs of caregivers of people with dementia composed new short-term psychotherapeutical intervention.

Detailed description

This prospective study will be offered to caregivers from the out patient clinic of the Department of Psychosomatic Medicine of the University Rostock Medical Center. In a first pilot study with 10 participants without control group, we tested the feasability and acceptance of the program (completed 2/2015). From 4/2015 a phase IIa study started with 10 participants in the intervention group and 10 in the control groups (will be organized by waiting list). The program consists of two modules of caregiver education followed by ten psychotherapeutic group modules. Duration of each module is planned to be 90 minutes including a relaxation exercise at the end of each module. Primary outcomes are the feasibility, acceptance and the effect on caregiver burden.

Interventions

BEHAVIORALPsychotherapy

The program is designed for 10 participants and consists of two modules of caregiver education followed by ten psychotherapeutic group modules. The major overarching topics will be (i) caregiver´s emotional and physical limits, (ii) conscious and unconscious feelings and emotions towards the people with dementia and (iii) activation of caregivers´ social resources. Duration of each module is planned to be 90 minutes including a relaxation exercise at the end of each module.

Sponsors

German Center for Neurodegenerative Diseases (DZNE)
CollaboratorOTHER
University of Rostock
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* caregiver of a person with dementia * willing to participate in all 12 modules of the program

Exclusion criteria

* current psychotherapy or antidepressive medication for less than 6 month * major depression

Design outcomes

Primary

MeasureTime frameDescription
Change in perceived self-efficacy directly and 3 month after psychotherapeutical intervention and reduction of symptoms of depressionbefore intervention, 0 and 3 month after end of interventionSWE, a german self-efficacy self-rating scale, will be used for self-efficacy measurement AND ADS (German Version of the CES-D Scale) for measurement for symptoms of depression

Secondary

MeasureTime frameDescription
reduction of perceived burden of carebefore intervention, 0 and 3 month after end of interventionWe will be using the Zarit-Burden-Interview to measure the perceived burden of care

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026